Side Effects of anagrelide: A Synthesis of Findings from 27 Studies
- Home
- Side Effects of anagrelide
This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Side Effects of anagrelide: A Synthesis of Findings from 27 Studies", please consult your doctor.
For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
Key Research Findings
Anagrelide is a medication used to reduce platelet count in patients with essential thrombocythemia (ET) and other myeloproliferative neoplasms (MPNs). 21 , 11 , 26 , 2 , 18 , 24 , 19 , 23 , 15 , 25 , 16 , 12 , 9 , 6 , 10 , 14 , 4 , 20 , 13 , 27 , 1 , 17 , 22 , 7 , 8 , 3 , 5 . Anagrelide is generally well-tolerated, but some common side effects may include headache and tachycardia. 16 , 12 , 19 , 1 . These side effects usually subside or disappear within a few weeks. 12 , 19 . Anagrelide may also affect the heart, so patients with heart disease should exercise caution. 26 , 2 . Anagrelide is considered a safer option for younger patients and is often preferred over hydroxyurea. 19 . However, anagrelide may be less effective than hydroxyurea, and combining both medications might be effective. 19 .
Reasons for Side Effects
Anagrelide is a phosphodiesterase 3 (PDE-3) inhibitor, and it works by suppressing megakaryocyte production, thus reducing platelet count. 14 , 12 , 1 . PDE-3 plays a crucial role in intracellular signaling, and by inhibiting this enzyme, anagrelide can affect the heart and blood vessels, potentially causing various side effects. 24 , 15 , 1 .
Common Side Effects
Headache
Headache is a common side effect of anagrelide. 16 , 12 , 13 , 7 . It is believed to be caused by anagrelide's vasodilatory effects. 16 . Headaches typically subside or disappear within a few weeks. 12 .
Tachycardia
Tachycardia, or rapid heartbeat, can also be a side effect of anagrelide. 16 , 12 , 19 , 1 . This is thought to be caused by anagrelide's positive inotropic and chronotropic effects on the heart. 24 , 15 , 1 . Tachycardia usually reduces or disappears within a few weeks. 12 , 19 .
Diarrhea
Diarrhea is another possible side effect of anagrelide. 16 , 12 , 7 . It is believed to be related to the effects of anagrelide on the digestive system. 16 . Diarrhea usually resolves or disappears within a few weeks. 12 .
Edema
Edema, or swelling, can also occur as a side effect of anagrelide. 16 , 12 , 7 . Edema is thought to be caused by anagrelide's vasodilatory effects. 16 . Edema can be treated with medications like diuretics. 16 .
Heart Failure
Anagrelide can worsen heart failure in patients who already have heart disease. 26 , 2 . Patients with heart disease should undergo a cardiac examination before starting anagrelide therapy. 26 .
Side Effect Management
Headache
Headache can be treated with over-the-counter pain relievers. 16 . If the headache is severe, the anagrelide dosage may need to be reduced or temporarily stopped. 16 .
Tachycardia
If tachycardia is severe, it can be treated with medications like beta-blockers. 1 . If tachycardia is severe, the anagrelide dosage may need to be reduced or temporarily stopped. 16 .
Diarrhea
Severe diarrhea can be treated with antidiarrheal medications. 16 . If diarrhea is severe, the anagrelide dosage may need to be reduced or temporarily stopped. 16 .
Edema
Edema can be treated with diuretics. 16 . If edema is severe, the anagrelide dosage may need to be reduced or temporarily stopped. 16 .
Heart Failure
Patients with heart failure should avoid anagrelide. 26 . If a patient with heart failure must receive anagrelide, it should be done under the supervision of a cardiologist. 26 .
Comparison Between Studies
Commonalities
Many studies have shown that anagrelide is effective in reducing platelet count. 21 , 11 , 26 , 2 , 18 , 24 , 19 , 23 , 15 , 25 , 16 , 12 , 9 , 6 , 10 , 14 , 4 , 20 , 13 , 27 , 1 , 17 , 22 , 7 , 8 , 3 , 5 . Studies also commonly report side effects like headache, tachycardia, diarrhea, and edema. 16 , 12 , 19 , 1 , 7 .
Differences
The incidence and severity of anagrelide side effects can vary across studies. 22 . This is likely due to differences in the patient populations studied, anagrelide dosage, and treatment duration. 22 . Studies also have differing opinions on whether anagrelide can affect the heart. 26 , 2 .
Real-World Application Considerations
Anagrelide is an effective treatment for ET and other MPNs, but it can cause side effects such as headache, tachycardia, diarrhea, and edema. 16 , 12 , 19 , 1 , 7 . While these side effects typically subside or disappear within a few weeks, if they become severe, the anagrelide dosage may need to be reduced or temporarily stopped. 16 , 12 , 19 . Anagrelide can affect the heart, so patients with heart disease should exercise caution. 26 , 2 . It's crucial to consult a doctor before starting anagrelide treatment and to have a thorough understanding of your medical condition and potential side effects. 26 , 2 .
Limitations of Current Research
There is still a lack of research on the long-term safety and effectiveness of anagrelide. 10 , 3 . More research is also needed to understand anagrelide's effects on the heart. 26 , 2 .
Future Research Directions
Further research is needed to investigate the long-term safety and effectiveness of anagrelide. 10 , 3 . A more thorough understanding of anagrelide's effects on the heart is also necessary. 26 , 2 . Additionally, research on combination therapy involving anagrelide and other medications is needed. 19 .
Conclusion
Anagrelide is an effective treatment for ET and other MPNs, but it can cause side effects such as headache, tachycardia, diarrhea, and edema. 16 , 12 , 19 , 1 , 7 . It's crucial to consult a doctor before starting anagrelide treatment and to have a thorough understanding of your medical condition and potential side effects. 26 , 2 . Research on the long-term safety and effectiveness of anagrelide is still ongoing, and further studies are needed to provide more comprehensive insights into its use. 10 , 3 .
Benefit Keywords
Risk Keywords
Article Type
Author: BadarFaraz, AzeezHayder, AbdulrahmanZeinab, AshrafAqsa, IftikharAsma
Language : English
Author: AnteloMaría Luisa, de Las HerasNatalia, Gonzalez PorrasJose Ramón, KerguelenAna, RayaJose María
Language : English
Author: StorenE C, TefferiA
Language : English
Author: MazzucconiM G, De SanctisV, ChistoliniA, DragoniF, MandelliF
Language : English
Author: SilversteinM N, PetittR M, SolbergL A, FlemingJ S, KnightR C, SchacterL P
Language : English
Author: SteurerMichael, GastlGuenther, JedrzejczakWieslaw-Wiktor, PytlikRobert, LinWerner, SchlöglErnst, GisslingerHeinz
Language : English
Author: MazurGrzegorz, WróbelTomasz, Podolak-DawidziakMaria, Kuliszkiewicz-JanusMałgorzata, PotoczekStanisław, NosolJustyna, KuliczkowskiKazimierz
Language : Polish
Author: MichielsJ J
Language : English
Author:
Language : English
Author: BirgegårdGunnar, BjörkholmMagnus, KuttiJack, LärfarsGerd, LöfvenbergEva, MarkevärnBerit, MerupMats, PalmbladJan, MauritzsonNils, WestinJan, SamuelssonJan
Language : English
Author: GilbertHarriet S
Language : English
Author: BirgegardGunnar
Language : English
Author: PetridesP E, BeykirchM K, TrappO M
Language : English
Author: TefferiA, SilversteinM N, PetittR M, MesaR A, SolbergL A
Language : English
Author: Rodriguez-ZiccardiMary, RubioManolo, LuMarvin, GreenspanAllan
Language : English
Author: GilbertHarriet S
Language : English
Author: DingliDavid, TefferiAyalew
Language : English
Author: ČervinekLibor, DoubekMichael, PenkaMiroslav, SchwarzJiří,
Language : Czech
Author: BirgegårdGunnar
Language : English
Author: BriereJ, GuilminF
Language : English
Author: DingliDavid, TefferiAyalew
Language : English
Author: GugliottaLuigi, TieghiAlessia, TortorellaGiovanni, ScalzulliPotito Rosario, CianciaRosanna, LunghiMonia, CacciolaEmma, CacciolaRossella, CandoniAnna, CrugnolaMonica, CodeluppiKatia, UsalaEmilio, SpecchiaGiorgina, MartinelliVincenzo, PalmieriFausto, PierriIvana, LiberatiAnna Marina, IurloAlessandra, GrossiAlberto, VannucchiAlessandro M, VianelliNicola, MazzucconiMaria Gabriella
Language : English
Author: TamaruSatoshi, TonoYasutaka, MatsumotoTakeshi, OdaHiroyasu, SugimotoYuka, MizunoToshiro, KatayamaNaoyuki, NishikawaMasakatsu
Language : English
Author: ProiettiRiccardo, RognoniAndrea, ArdizzoneFabio, MaccioSergio, SantagostinoAlberto, RognoniGiorgio
Language : English
Author: MazzucconiMaria Gabriella, BaldacciErmina, LatagliataRoberto, BrecciaMassimo, PaoloniFrancesca, Di VeroliAmbra, CedroneMichele, AnaclericoBarbara, VillivàNicoletta, PorriniRaffaele, MontefuscoEnrico, AndrianiAlessandro, MontanaroMarco, ScaramucciLaura, SpadeaAntonio, RagoAngela, CiminoGiuseppe, SpiritoFrancesca, SantoroCristina
Language : English
Author: BirgegårdGunnar
Language : English
Author: MalkanUmit Yavuz, GunesGursel, EliacikEylem, YayarOkan, HaznedarogluIbrahim Celalettin
Language : English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.